No Result

View All Result

No products in the cart.

2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑

Home StudyGraphics

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

byKathleen Lau

January 29, 2021

in StudyGraphics

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

RELATED REPORTS

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Daraxonrasib extends survival in metastatic pancreatic cancer

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

Dihydroartemisinin-piperaquine reduces children death or readmission with severe anemia

RelatedReports

Chronic Disease

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

September 22, 2026

Oncology

Daraxonrasib extends survival in metastatic pancreatic cancer

September 17, 2026

Emergency

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

September 16, 2026

Cardiology

Borderline-low hemoglobin levels linked to increased mortality

September 14, 2026

Colchicine may lower the risk of cardiovascular events in patients with coronary disease

2 Minute Medicine Rewind Jan 25, 2021

Majority of obese tenth-graders already obese by fifth grade

Time restricted eating effective as a modest weight loss strategy for obese adults

Prescription of antibiotics for acute respiratory infections increasing

Tocilizumab not superior to standard care in randomized controlled trial for severe COVID-19 patients

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Higher risk of mortality during COVID-19 infection among patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib at COVID-19 diagnosis

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Daraxonrasib extends survival in metastatic pancreatic cancer

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

Dihydroartemisinin-piperaquine reduces children death or readmission with severe anemia

2 Minute Medicine Rewind Jan 25, 2021

RelatedReports

The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality

Daraxonrasib extends survival in metastatic pancreatic cancer

A lower threshold for referral to the emergency department for outpatient hyperkalemia may reduce mortality

Borderline-low hemoglobin levels linked to increased mortality

2 Minute Medicine Rewind Jan 25, 2021

Time restricted eating effective as a modest weight loss strategy for obese adults

Tocilizumab not superior to standard care in randomized controlled trial for severe COVID-19 patients

2MM+ All Access

Recent Reports

The medical literature, distilled daily.

Membership benefits